Related references
Note: Only part of the references are listed.Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
Tomáš Šimůnek et al.
Pharmacological Reports (2014)
Therapeutic applications of PI3K inhibitors in cardiovascular diseases
Alessandra Ghigo et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Protein biomarkers of drug-induced cardiotoxicity in the isolated heart: Building a multi-scale approach
Brandon Borders et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2013)
Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
Jian Wang et al.
CELL RESEARCH (2012)
Inhibition of miR-15 Protects Against Cardiac Ischemic Injury
Thomas G. Hullinger et al.
CIRCULATION RESEARCH (2012)
MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients
Simona Greco et al.
DIABETES (2012)
Micro-RNA-34a Contributes to the Impaired Function of Bone Marrow-Derived Mononuclear Cells From Patients With Cardiovascular Disease
Quanfu Xu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-like immunochemotherapy
Dima El-Sharkawi et al.
LEUKEMIA & LYMPHOMA (2012)
BIOMARKERS Pros and cons of high-sensitivity assays for cardiac troponin
Evangelos Giannitsis et al.
NATURE REVIEWS CARDIOLOGY (2012)
Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment
Caterina Vacchi-Suzzi et al.
PLOS ONE (2012)
Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function
Bianca C. Bernardo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction
Benjamin Meder et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Assessment of Plasma miRNAs in Congestive Heart Failure
Yasue Fukushima et al.
CIRCULATION JOURNAL (2011)
Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage
Yasuhide Kuwabara et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2011)
Relationship Between the Temporal Profile of Plasma microRNA and Left Ventricular Remodeling in Patients After Myocardial Infarction
Michael R. Zile et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2011)
Circulating MicroRNAs are Promising Novel Biomarkers of Acute Myocardial Infarction
Rongrong Wang et al.
INTERNAL MEDICINE (2011)
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome
Christian Widera et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Extracellular microRNA: A new source of biomarkers
Alton Etheridge et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1
Riccardo Perbellini et al.
NEUROMUSCULAR DISORDERS (2011)
Role of miR-1 and miR-133a in myocardial ischemic postconditioning
Bin He et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
Regulation of mRNA Translation and Stability by microRNAs
Marc Robert Fabian et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction
Jing Ai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The peripheral blood mononuclear cell microRNA signature of coronary artery disease
Menno Hoekstra et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway
Takahiro Horie et al.
CARDIOVASCULAR RESEARCH (2010)
Mechanisms of Myocyte Cytotoxicity Induced by the Multikinase Inhibitor Sorafenib
Brian B. Hasinoff et al.
CARDIOVASCULAR TOXICOLOGY (2010)
MiR423-5p As a Circulating Biomarker for Heart Failure
Anke J. Tijsen et al.
CIRCULATION RESEARCH (2010)
Circulating MicroRNAs in Patients With Coronary Artery Disease
Stephan Fichtlscherer et al.
CIRCULATION RESEARCH (2010)
Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease
Maarten F. Corsten et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
β-Thalassemia Cardiomyopathy History, Present Considerations, and Future Perspectives
Dimitrios T. Kremastinos et al.
CIRCULATION-HEART FAILURE (2010)
Plasma MicroRNA 499 as a Biomarker of Acute Myocardial Infarction
Taichi Adachi et al.
CLINICAL CHEMISTRY (2010)
A translational study of circulating cell-free microRNA-1 in acute myocardial infarction
Yunhui Cheng et al.
CLINICAL SCIENCE (2010)
Gene expression profiling in whole blood of patients with coronary artery disease
Chiara Taurino et al.
CLINICAL SCIENCE (2010)
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction
Yuri D'Alessandra et al.
EUROPEAN HEART JOURNAL (2010)
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans
Guo-Kun Wang et al.
EUROPEAN HEART JOURNAL (2010)
Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma
T. Nousiainen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
PLASMA MICRORNA-361-5P AS A BIOMARKER OF CHRONIC HEART FAILURE
Chen Chen et al.
HEART (2010)
MicroRNA-15b Modulates Cellular ATP Levels and Degenerates Mitochondria via Arl2 in Neonatal Rat Cardiac Myocytes
Hitoo Nishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
Xin An et al.
LEUKEMIA RESEARCH (2010)
Nilotinib: A second-generation tyrosine kinase inhibitor for chronic myeloid leukemia
Massimo Breccia et al.
LEUKEMIA RESEARCH (2010)
MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis
Stefania Nicoli et al.
NATURE (2010)
MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients
Christine Voellenkle et al.
PHYSIOLOGICAL GENOMICS (2010)
Exosomes from human saliva as a source of microRNA biomarkers
A. Michael et al.
ORAL DISEASES (2010)
Cardiotoxicity induced by tyrosine kinase inhibitors
George S. Orphanos et al.
ACTA ONCOLOGICA (2009)
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins
Yun Bian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs
Neil Ashley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The relationship between cell membrane damage and lipid peroxidation under the condition of hypoxia-reoxygenation: analysis of the mechanism using antioxidants and electron transport inhibitors
Daisuke Yajima et al.
CELL BIOCHEMISTRY AND FUNCTION (2009)
The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease
L. Ella et al.
CELL DEATH AND DIFFERENTIATION (2009)
MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation
Yunhui Cheng et al.
CIRCULATION RESEARCH (2009)
Plasma miR-208 as a Biomarker of Myocardial Injury
Xu Ji et al.
CLINICAL CHEMISTRY (2009)
The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl
Michael J. Eck et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
A Family of microRNAs Encoded by Myosin Genes Governs Myosin Expression and Muscle Performance
Eva van Rooij et al.
DEVELOPMENTAL CELL (2009)
Rational drug design
Soma Mandal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis
Coen van Solingen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice
Thomas E. Callis et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity
Derrick J. Gibbings et al.
NATURE CELL BIOLOGY (2009)
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
Jeffrey S. Ross et al.
ONCOLOGIST (2009)
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Angelika Bonauer et al.
SCIENCE (2009)
Heart failure associated with sunitinib malate - A multitargeted receptor tyrosine kinase inhibitor
Aarif Y. Khakoo et al.
CANCER (2008)
Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics
Ming Hui Chen et al.
CIRCULATION (2008)
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Lin Xia et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
BNP cannot replace gated equilibrium radionuclide ventriculography in monitoring of anthracycline-induced cardiotoxity
Thomas W. Vogelsang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu
Alessandro D. Santin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2008)
Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart
Xiaobin Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy
F. J. F. Broeyer et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Manuela Schmidinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
miRNAs at the heart of the matter
Zhiguo Wang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Mechanisms of Myocyte Cytotoxicity Induced by the Multiple Receptor Tyrosine Kinase Inhibitor Sunitinib
Brian B. Hasinoff et al.
MOLECULAR PHARMACOLOGY (2008)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
Serum MicroRNAs Are Promising Novel Biomarkers
Shlomit Gilad et al.
PLOS ONE (2008)
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133
Ning Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F. Chu et al.
LANCET (2007)
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
Thomas M. Suter et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution
Maike Schmidt et al.
DEVELOPMENT (2007)
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Guido T. Bommer et al.
CURRENT BIOLOGY (2007)
MicroRNAs in the human heart - A clue to fetal gene reprogramming in heart failure
Thomas Thum et al.
CIRCULATION (2007)
Signal integration in the endoplasmic reticulum unfolded protein response
David Ron et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation
Ruirui Ji et al.
CIRCULATION RESEARCH (2007)
Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure
Igor P. Pogribny et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)
A complex system of small RNAs in the unicellular green alga Chlamydomonas reinhardtii
Tao Zhao et al.
GENES & DEVELOPMENT (2007)
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
Thomas Force et al.
NATURE REVIEWS CANCER (2007)
Control of stress-dependent cardiac growth and gene expression by a microRNA
Eva van Rooij et al.
SCIENCE (2007)
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2
Yong Zhao et al.
CELL (2007)
PI3K(p110α) inhibitors as anti-cancer agents -: Minding the heart
Julie R. McMullen et al.
CELL CYCLE (2007)
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2
Baofeng Yang et al.
NATURE MEDICINE (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy
Julie R. McMullen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Dasatinib: a new step in molecular target therapy
A. Olivieri et al.
ANNALS OF ONCOLOGY (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
RNA polymerase III transcribes human microRNAs
Glen M. Borchert et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
BNP as a marker of the heart failure in the treatment of imatinib mesylate
Yeon Hee Park et al.
CANCER LETTERS (2006)
DNA damage is an early event in doxorubicin-induced cardiac myocyte death
Thomas L'Ecuyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Risto Kerkela et al.
NATURE MEDICINE (2006)
Biomarkers of cardiovascular disease - Molecular basis and practical considerations
Ramachandran S. Vasan
CIRCULATION (2006)
Control of translation and mRNA degradation by miRNAs and siRNAs
MA Valencia-Sanchez et al.
GENES & DEVELOPMENT (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
M Cully et al.
NATURE REVIEWS CANCER (2006)
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
JF Chen et al.
NATURE GENETICS (2006)
Comprehensive thermodynamic analysis of 3 ' double-nucleotide overhangs neighboring Watson-Crick terminal base pairs
Amanda S. O'Toole et al.
NUCLEIC ACIDS RESEARCH (2006)
Serum chemical biomarkers of cardiac injury for nonclinical safety testing
DB Walker
TOXICOLOGIC PATHOLOGY (2006)
Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia
PW Manley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies
KA Wouters et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Evaluation of H-FABP as a marker of ongoing myocardial damage using hGH transgenic mice
H Naraoka et al.
CLINICA CHIMICA ACTA (2005)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: A marker predictive of cardiac dysfunction?
MT Sandri et al.
CLINICAL CHEMISTRY (2005)
Tyrosine kinases as targets for cancer therapy
DS Krause et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis
Y Zhao et al.
NATURE (2005)
MicroRNA expression in zebrafish embryonic development
E Wienholds et al.
SCIENCE (2005)
Apoptosis-modulating interaction of the neuregulin/erbB pathway with antracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes
S Rohrbach et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Iron trafficking in the mitochondrion: novel pathways revealed by disease
I Napier et al.
BLOOD (2005)
Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction
G Daugaard et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice
XW Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes
CC Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
MicroRNA genes are transcribed by RNA polymerase II
Y Lee et al.
EMBO JOURNAL (2004)
Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis
O Yamaguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Serum troponins as biomarkers of drug-induced cardiac toxicity
KB Wallace et al.
TOXICOLOGIC PATHOLOGY (2004)
Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs
DP Bartel et al.
NATURE REVIEWS GENETICS (2004)
Doxorubicin-induced cardiac mitochondrionopathy
KB Wallace
PHARMACOLOGY & TOXICOLOGY (2003)
C-reactive protein: a critical update
MB Pepys et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogeneic stem cell transplantation with busulphan/cyclophosphamide conditioning after imatinib mesylate administration
SK Sohn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: Inhibition of the ferritin iron mobilization pathway
JC Kwok et al.
MOLECULAR PHARMACOLOGY (2003)
Childhood cancer survival in Europe and the United States
G Gatta et al.
CANCER (2002)
Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis
PS Green et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
AS Maisel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children:: a systematic review
LCM Kremer et al.
ANNALS OF ONCOLOGY (2002)
Chemo therapy-induced cardiotoxicity: current practice and prospects of prophylaxis
MI Gharib et al.
EUROPEAN JOURNAL OF HEART FAILURE (2002)
Identification of tissue-specific microRNAs from mouse
M Lagos-Quintana et al.
CURRENT BIOLOGY (2002)
Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1β and anti-erbB2 -: Potential mechanism for trastuzumab-induced cardiotoxicity
DB Sawyer et al.
CIRCULATION (2002)
Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction
T Nousiainen et al.
JOURNAL OF INTERNAL MEDICINE (2002)
Detection of relapse in non-Hodgkin's lymphoma: Role of routine follow-up studies
A Elis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Cardiac dysfunction in the trastuzumab clinical trials experience
A Seidman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Comprehensive guidelines for the diagnosis and treatment of chronic heart failure - Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology
WJ Remme et al.
EUROPEAN JOURNAL OF HEART FAILURE (2002)
Smart drugs: Tyrosine kinase inhibitors in cancer therapy
LK Shawver et al.
CANCER CELL (2002)
Measurement of cardiac troponins
PO Collinson et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review
EL De Beer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Long-term chemotherapy-related cardiovascular morbidity
MT Meinardi et al.
CANCER TREATMENT REVIEWS (2000)
Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
JS Alpert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Induction of apoptosis by cancer chemotherapy
SH Kaufmann et al.
EXPERIMENTAL CELL RESEARCH (2000)
Cardiotoxicity of chemotherapeutic agents - Incidence, treatment and prevention
VB Pai et al.
DRUG SAFETY (2000)
Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia
BJ Druker et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity
H Okumura et al.
ACTA HAEMATOLOGICA (2000)
Share Paper
